Beranda › Kanker Prostat › California › Mountain View
Uji klinis Kanker Prostat di Mountain View, CA
15 studi untuk Kanker Prostat mencari peserta di lokasi sekitar Mountain View (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Menerima pesertaFase 3
- Stanford Cancer Center ( Site 0036), Palo Alto · 5 mi jauhnya
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Menerima pesertaFase 2/3
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauhnya
- Stanford University Medical Center, Palo Alto · 5 mi jauhnya
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Menerima pesertaFase 1
- Stanford University Medical Center, Stanford · 5 mi jauhnya
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Menerima pesertaFase 3
- Stanford University Medical Center, Palo Alto · 5 mi jauhnya
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Menerima pesertaFase 3
- Stanford Cancer Center ( Site 0046), Palo Alto · 5 mi jauhnya
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Menerima peserta
- USNC, Mountain View
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
Menerima pesertaFase 3
- Stanford University Medical Center, Stanford · 5 mi jauhnya
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Menerima pesertaFase 1
- Investigational Site Number: 403, Palo Alto · 5 mi jauhnya
Prostate Active Surveillance Study
Menerima pesertaStudi observasional
- Stanford University, Stanford · 5 mi jauhnya
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi jauhnya
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
Menerima pesertaFase 1
- Stanford Cancer Center, Palo Alto · 5 mi jauhnya
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Menerima pesertaFase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauhnya
- VA Palo Alto Health Care System, Palo Alto · 5 mi jauhnya
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
Menerima pesertaFase 1
- Research Site, Palo Alto · 5 mi jauhnya
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Stanford · 5 mi jauhnya
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Menerima pesertaFase 3
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi jauhnya
Uji klinis Kanker Prostat di kota lain
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Studi lain di Mountain View
- Kanker (semua jenis)40 studi
- Kanker Payudara25 studi
- Kanker Metastatik25 studi
- Kanker Paru Non-Sel Kecil21 studi
- Leukemia Mieloid Akut19 studi
- Kanker Ovarium19 studi
- Gangguan Spektrum Autisme17 studi
- Kanker Paru17 studi
- Gagal Jantung15 studi
- Autisme13 studi
- Leukemia Limfoblastik Akut13 studi
- Kanker Kolorektal13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.